DK3568023T3 - Sterilfiltreret lactasepræparat, som omfatter salt med monovalent kation, og fremstilling deraf - Google Patents

Sterilfiltreret lactasepræparat, som omfatter salt med monovalent kation, og fremstilling deraf Download PDF

Info

Publication number
DK3568023T3
DK3568023T3 DK18702108.4T DK18702108T DK3568023T3 DK 3568023 T3 DK3568023 T3 DK 3568023T3 DK 18702108 T DK18702108 T DK 18702108T DK 3568023 T3 DK3568023 T3 DK 3568023T3
Authority
DK
Denmark
Prior art keywords
preparation
sterile filtered
monovalent cation
cation salt
filtered lactase
Prior art date
Application number
DK18702108.4T
Other languages
English (en)
Inventor
Cedric Hobel
Karen Jensen
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Application granted granted Critical
Publication of DK3568023T3 publication Critical patent/DK3568023T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1206—Lactose hydrolysing enzymes, e.g. lactase, beta-galactosidase
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01108—Lactase (3.2.1.108)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dairy Products (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK18702108.4T 2017-01-13 2018-01-12 Sterilfiltreret lactasepræparat, som omfatter salt med monovalent kation, og fremstilling deraf DK3568023T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17151473 2017-01-13
EP17173248 2017-05-29
PCT/EP2018/050758 WO2018130654A1 (en) 2017-01-13 2018-01-12 Sterile filtered lactase preparation comprising salt with monovalent cation

Publications (1)

Publication Number Publication Date
DK3568023T3 true DK3568023T3 (da) 2021-10-04

Family

ID=61094425

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18702108.4T DK3568023T3 (da) 2017-01-13 2018-01-12 Sterilfiltreret lactasepræparat, som omfatter salt med monovalent kation, og fremstilling deraf

Country Status (7)

Country Link
US (2) US11576393B2 (da)
EP (1) EP3568023B1 (da)
CN (1) CN110167352A (da)
BR (1) BR112019014432B1 (da)
DK (1) DK3568023T3 (da)
PL (1) PL3568023T3 (da)
WO (1) WO2018130654A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112707940B (zh) * 2020-12-28 2022-07-01 中国科学院青岛生物能源与过程研究所 一种甘油葡糖苷的杀菌方法
WO2023288294A1 (en) 2021-07-16 2023-01-19 Novozymes A/S Compositions and methods for improving the rainfastness of proteins on plant surfaces
IT202100019244A1 (it) * 2021-07-20 2023-01-20 Mauro Marchetti Metodo di produzione di un prodotto caseario
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
WO2023237360A1 (en) 2022-06-07 2023-12-14 Chr. Hansen A/S Improving filterability of lactase by adding anions selected from malate, tartrate, citrate, gluconate, edta or combinations thereof and sterile filtered lactase product obtained

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE438773B (sv) 1974-11-13 1985-05-13 Tetra Pak Int Sett att framstella en steril mejeriprodukt med nedsatt halt av laktos
JPS53148591A (en) 1977-05-31 1978-12-25 Daiwa Kasei Kk Production of novel lactase
FR2500269A1 (fr) 1981-02-20 1982-08-27 Tetra Pak Int Procede pour le traitement des produits laitiers pour diminuer leur teneur en lactose notamment
EP0074237B1 (en) 1981-09-01 1985-04-24 JOHN & E STURGE LIMITED Stabilised lactase solutions and processes for stabilisation
AU586809B2 (en) 1983-12-02 1989-07-27 Gist-Brocades N.V. Process for the preparation of a germ free solution of a lactose-splitting enzyme and its use.
US5357852A (en) 1992-06-02 1994-10-25 Kohler Mix Specialties Method and apparatus for producing reduced lactose milk
ES2564821T3 (es) * 2001-04-04 2016-03-29 Dsm Ip Assets B.V. Lactasa purificada
CN100497613C (zh) 2006-09-08 2009-06-10 哈尔滨美华生物技术股份有限公司 中性液体乳糖酶生产方法
WO2009071539A1 (en) 2007-12-03 2009-06-11 Novozymes A/S Method for producing a dairy product
CN102264238A (zh) 2008-10-23 2011-11-30 株式会社明治 发酵乳清调制物及其制造法
WO2013084244A1 (en) 2011-12-05 2013-06-13 Medreich Limited Stable lactase drops
JP6024545B2 (ja) 2013-03-19 2016-11-16 住友金属鉱山株式会社 酸化亜鉛系焼結体とその製造方法およびスパッタリングターゲット
US9840723B2 (en) 2013-05-14 2017-12-12 Novozymes A/S Process for simultaneous saccharfication and fermentation of whey permeate
CN106061293A (zh) 2014-03-05 2016-10-26 帝斯曼知识产权资产管理有限公司 液体乳糖酶组合物
WO2016031885A1 (ja) * 2014-08-27 2016-03-03 合同酒精株式会社 ラクターゼ溶液及びそれを用いた乳
GB201419900D0 (en) 2014-11-07 2014-12-24 Dupont Nutrition Biosci Aps Method

Also Published As

Publication number Publication date
US20230225345A1 (en) 2023-07-20
US11576393B2 (en) 2023-02-14
CN110167352A (zh) 2019-08-23
WO2018130654A1 (en) 2018-07-19
BR112019014432A2 (pt) 2020-04-14
EP3568023B1 (en) 2021-07-07
US20200221721A1 (en) 2020-07-16
PL3568023T3 (pl) 2021-12-27
EP3568023A1 (en) 2019-11-20
BR112019014432B1 (pt) 2023-10-24

Similar Documents

Publication Publication Date Title
DK3568023T3 (da) Sterilfiltreret lactasepræparat, som omfatter salt med monovalent kation, og fremstilling deraf
HK1251546A1 (zh) S-氯胺酮的(s)-csa鹽、s-氯胺酮的(r)-csa鹽和用於製備s-氯胺酮的方法
DK3393412T3 (da) Øjenimplantatsystemer
DK3513809T3 (da) Medicinsk sammensætning, som omfatter tivozanib
MA42844A (fr) Combinaisons thérapeutiques comprenant des immunoconjugués anti-folr1
ZA201708392B (en) Savoury concentrate comprising inorganic salt, fat and xanthan gum
DK3393579T3 (da) Øjenbehandlingssystem
DK3137168T3 (da) Substituerede 4-phenylpiperidiner, deres fremstilling og anvendelse
ZA201904395B (en) Treatment fluid preparation system
ZA201800489B (en) Savoury concentrate comprising inorganic salt, fat and polysaccharide gums
DK3326971T3 (da) Antimikrobielt, insekticidt og akaricidt system
DK3277287T3 (da) Blandinger af humane mælke-oligosaccharider, der omfatter 3 '-o-sialyllactose
ZA201800507B (en) Savoury concentrate comprising inorganic salt, fat and carboxymethyl cellulose
ZA201704743B (en) Mangiferin-6-o-berberine salt and preparation method and use thereof
DK3355933T3 (da) Adeninkonjugatforbindelser og deres anvendelse som vaccineadjuvanser
DK3344289T3 (da) Pestivirusvacciner mod medfødt tremor
DK3325027T3 (da) Medicinsk implantat
DK3096610T3 (da) Æggebrydningssystemer og -fremgangsmåder
DK3352735T3 (da) Olanzapinformuleringer med langvarig frigivelse
ME03727B (me) Zamjena za so i njena primena
ZA201800490B (en) Savoury concentrate comprising inorganic salt, fat and gellan gum
HK1248472A1 (zh) 以吡啶衍生物或其鹽作為有效成分的香味調製劑
DK3649080T3 (da) Ammoniakfremstillingsfremgangsmåde
ZA201800607B (en) Savoury concentrate comprising inorganic salt, fat and heteropolysaccharide gum
ITUB20160291A1 (it) Preparazione riassorbibile per usi medicali, e usi particolari di tale preparazione